[Antipsychotic neuroplegics and neuroleptics. VII. Butyrophenones (Part 2)].
D000759:Adjuvants, Anesthesia; D000932:Antiemetics / Q000008:administration & dosage / Q000009:adverse effects; D001143:Arousal / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D002090:Butyrophenones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003243:Consciousness / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D004409:Dyskinesia, Drug-Induced; D004702:Endocrine Glands / Q000187:drug effects; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects; D008660:Metabolism / Q000187:drug effects; D011605:Psychoses, Substance-Induced; D012119:Respiration / Q000187:drug effects; D012769:Shock / Q000517:prevention & control; D013405:Suicide; D014590:Uterine Contraction / Q000187:drug effects
D000759:Adjuvants, Anesthesia; D000932:Antiemetics; D002090:Butyrophenones; D006993:Hypnotics and Sedatives
Neuroplégiques et neuroleptiques antipsychotiques VII. Butyrophénones (2éme partie).